Subscribe to RSS
Barriers and Support-System while Considering Hematopoietic Stem Cell Transplant (HSCT): A Qualitative Study of Pre-HSCT Acute Leukemia Patients from a Standalone Transplant Laboratory in IndiaSource of Funding No funding has been received for the present study.
Introduction Hematopoietic stem cell transplant (HSCT) is the definite treatment for acute leukemia but considering HSCT is challenging for the patients. There are many studies that have described the patients’ experience after HSCT but very few studies have reported their experience before going for HSCT and there is no published report in India on patients’ experience before HSCT.
Objective We conducted a qualitative study to understand barriers, and support-system while considering HSCT and the chances of getting matched unrelated donor (MUD) for these patients.
Materials and Methods The present study was a qualitative study. Demographic details of 514 patients who consented for the study were noted and the patients and their families were interviewed using a semistructured interview booklet before HSCT. The interview sessions were recorded, transcribed verbatim, and analyzed for emerging themes. The study data were analyzed using QDA Miner Lite 4.0 software (Provalis Research, Montreal, Canada). Descriptive statistics such as frequency and percentage were used. The chances of getting a human leukocyte antigen (HLA)-matched donor were also computed by “HLA-matching software.”
Results Acute myeloid leukemia (64.01%) was commoner than acute lymphoid leukemia (35.99%) with male: female ratio as 1.98:1. The study showed nine themes as barriers and six themes emerged in regard to the support system for HSCT decision making. The biggest barriers identified among these patients pre-HSCT were related to cost, probability of “success of transplant,” and probable “quality of life.” The family support was the biggest support system variable followed by “treating doctor.” The chances of getting a MUD for these patients were 13.22% and 5.44% in global and Indian data pool, respectively.
Conclusion Deciding upon HSCT can be challenging for patients and understanding of barriers and support-system variables among these patients would provide important insights and help design better counseling techniques for such patients of HSCT and future studies in this context.
Keywordsacute leukemia - barriers - hematopoietic stem cell transplant (HSCT) - matched unrelated donor (MUD) - support-system
06 August 2021 (online)
© 2021. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India
- 1 Singh AK, McGuirk JP. Allogeneic stem cell transplantation: a historical and scientific overview. Cancer Res 2016; 76 (22) 6445-6451
- 2 Sharma SK, Choudhary D, Gupta N. et al. Cost of hematopoietic stem cell transplantation in India. Mediterr J Hematol Infect Dis 2014; 6 (01) 2014046
- 3 Michael A. Andrykowski, Richard P. Psychosocial issues in hematopoietic cell transplantation. In: Thomas ED, Forman SJ, Appelbaum FR, Blume KG, eds.. Thomas, hematopoietic cell transplantation. 3rd ed. Blackwell 2004; 497-506
- 4 GENEBANDHU. Available at: www.genebandhu.in. Accessed April 13, 2021
- 5 WMDA. Available at: https://www.wmda.info. Accessed April 13, 2021
- 6 Akaho R, Sasaki T, Mori S. et al. Psychological factors and survival after bone marrow transplantation in patients with leukemia. Psychiatry Clin Neurosci 2003; 57 (01) 91-96
- 7 Selby GB, Ali LI, Carter TH, Veseley S, Roy V. The influence of health insurance on outcomes of related-donor hematopoietic stem cell transplantation for AML and CML. Biol Blood Marrow Transplant 2001; 7 (10) 576
- 8 Farroni JS, Thompson PA, Arif D, Corted JE, Gallagher CM. Ethical issues in patients with leukemia: practice points and educational topics for the clinical oncologist and trainees. J Clin Res Bioeth 2017; 5: 314
- 9 Khemani K, Ross D, Sinha C, Haight A, Bakshi N, Krishnamurti L. Experiences and decision making in hematopoietic stem cell transplant in sickle cell disease: patients’ and caregivers’ perspectives. Biol Blood Marrow Transplant 2018; 24 (05) 1041-1048
- 10 Chakrabarti S, Bareford D. A survey on patient perception of reduced-intensity transplantation in adults with sickle cell disease. Bone Marrow Transplant 2007; 39 (08) 447-451
- 11 Cooke L, Gemmill R, Kravits K, Grant M. Psychological issues of stem cell transplant. Semin Oncol Nurs 2009; 25 (02) 139-150
- 12 Siston AK, List MA, Daugherty CK. et al. Psychosocial adjustment of patients and caregivers prior to allogeneic bone marrow transplantation. Bone Marrow Transplant 2001; 27 (11) 1181-1188
- 13 Pelletier W, Hinds PS, Alderfer MA, Fairclough DL, Stegenga K, Pentz RD. Themes reported by families as important when proceeding with pediatric hematopoietic stem cell transplantation. Pediatr Blood Cancer 2014; 61 (09) 1625-1631
- 14 Johnson KS, Elbert-Avila KI, Tulsky JA. The influence of spiritual beliefs and practices on the treatment preferences of African Americans: a review of the literature. J Am Geriatr Soc 2005; 53 (04) 711-719
- 15 Ragsdale JR, Hegner MA, Mueller M, Davies S. Identifying religious and/or spiritual perspectives of adolescents and young adults receiving blood and marrow transplants: a prospective qualitative study. Biol Blood Marrow Transplant 2014; 20 (08) 1242-1247
- 16 Berry DL, Blonquist TM, Pozzar R, Nayak MM. Understanding health decision making: an exploration of homophily. Soc Sci Med 2018; 214: 118-124
- 17 Tiwari AK, Bhati-Kushwaha H, Kukreja P. et al. Probability of finding marrow unrelated donor (MUD) for an Indian patient in a multi-national human leukocyte antigen (HLA) registry. Indian J Hematol Blood Transfus 2015; 31 (02) 186-195
- 18 Tiwari AK, Mishra VC, Tiwari A. et al. Matched unrelated donor hematopoietic progenitor cell transplantation: a report based on a single registry in India. Leuk Res Rep 2019; 11: 17-20
- 19 Gragert L, Eapen M, Williams E. et al. HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry. N Engl J Med 2014; 371 (04) 339-348